Condensed Balance Sheets (USD $)	Mar. 31, 2012	Dec. 31, 2011
ASSETS
Cash and cash equivalents	$ 1,471,979	$ 1,484,906
TOTAL ASSETS	1,471,979	1,484,906
CURRENT LIABILITIES
Accounts payable and accrued expenses	26,384	9,174
Warrant liability	36,826	70,991
TOTAL CURRENT LIABILITIES	63,210	80,165
COMMITMENTS AND CONTINGENCIES
PREFERRED STOCK, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible Preferred stock; 50,000 shares authorized; 20,637 and 20,637 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively: liquidation preference of $2,063,700 and $2,063,700 as of March 31, 2012 and December 31, 2011, respectively	1,985,181	1,951,846
STOCKHOLDERS' DEFICIT
Common stock, $.10 par value 200,000,000 shares authorized; 15,536,275 shares issued and outstanding as of March 31, 2012 and December 31, 2011	1,553,628	1,553,628
Additional paid-in capital	2,559,145	2,559,145
Accumulated deficit	(3,626,121)	(3,626,121)
Deficit accumulated during the development stage	(1,063,064)	(1,033,757)
TOTAL STOCKHOLDERS' DEFICIT	(576,412)	(547,105)
TOTAL LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS' DEFICIT	$ 1,471,979	$ 1,484,906